Cigna Investments’s Goldman Sachs GS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.77M | Sell |
2,738
-69
| -2% | -$67.3K | 0.36% | 45 |
|
|
2026
Q1 | $2.37M | Sell |
2,807
-40
| -1% | -$35.7K | 0.37% | 43 |
|
|
2025
Q4 | $2.5M | Sell |
2,847
-67
| -2% | -$54.7K | 0.36% | 43 |
|
|
2025
Q3 | $2.32M | Sell |
2,914
-74
| -2% | -$54.8K | 0.33% | 42 |
|
|
2025
Q2 | $2.11M | Sell |
2,988
-67
| -2% | -$38.8K | 0.36% | 45 |
|
|
2025
Q1 | $1.67M | Sell |
3,055
-101
| -3% | -$60.8K | 0.31% | 58 |
|
|
2024
Q4 | $1.81M | Sell |
3,156
-113
| -3% | -$63K | 0.32% | 53 |
|
|
2024
Q3 | $1.62M | Sell |
3,269
-58
| -2% | -$28.4K | 0.28% | 67 |
|
|
2024
Q2 | $1.5M | Sell |
3,327
-23
| -0.7% | -$10.1K | 0.28% | 65 |
|
|
2024
Q1 | $1.4M | Sell |
3,350
-70
| -2% | -$27.2K | 0.26% | 74 |
|
|
2023
Q4 | $1.32M | Sell |
3,420
-57
| -2% | -$19K | 0.27% | 76 |
|
|
2023
Q3 | $1.13M | Sell |
3,477
-480
| -12% | -$160K | 0.26% | 81 |
|
|
2023
Q2 | $1.28M | Sell |
3,957
-76
| -2% | -$25K | 0.24% | 85 |
|
|
2023
Q1 | $1.32M | Sell |
4,033
-86
| -2% | -$29.9K | 0.26% | 79 |
|
|
2022
Q4 | $1.42M | Sell |
4,119
-22
| -0.5% | -$7.66K | 0.29% | 72 |
|
|
2022
Q3 | $1.21M | Sell |
4,141
-189
| -4% | -$61.2K | 0.27% | 78 |
|
|
2022
Q2 | $1.29M | Sell |
4,330
-1,565
| -27% | -$487K | 0.26% | 78 |
|
|
2022
Q1 | $1.95M | Sell |
5,895
-1,771
| -23% | -$625K | 0.24% | 84 |
|
|
2021
Q4 | $2.93M | Sell |
7,666
-2,676
| -26% | -$1.06M | 0.23% | 76 |
|
|
2021
Q3 | $3.91M | Sell |
10,342
-250
| -2% | -$97.6K | 0.29% | 68 |
|
|
2021
Q2 | $4.02M | Sell |
10,592
-1,735
| -14% | -$621K | 0.29% | 72 |
|
|
2021
Q1 | $4.03M | Buy |
12,327
+318
| +3% | +$99K | 0.28% | 75 |
|
|
2020
Q4 | $3.17M | Buy |
12,009
+1,001
| +9% | +$223K | 0.24% | 80 |
|
|
2020
Q3 | $2.21M | Buy |
11,008
+749
| +7% | +$152K | 0.21% | 91 |
|
|
2020
Q2 | $2.03M | Buy |
10,259
+1,263
| +14% | +$237K | 0.19% | 102 |
|
|
2020
Q1 | $1.39M | Buy |
8,996
+520
| +6% | +$110K | 0.18% | 120 |
|
|
2019
Q4 | $2.02M | Sell |
8,476
-1,107
| -12% | -$240K | 0.21% | 96 |
|
|
2019
Q3 | $2.04M | Buy |
9,583
+50
| +0.5% | +$10.5K | 0.21% | 101 |
|
|
2019
Q2 | $2.1M | Sell |
9,533
-463
| -5% | -$91.6K | 0.23% | 91 |
|
|
2019
Q1 | $1.92M | Sell |
9,996
-277
| -3% | -$53.4K | 0.21% | 93 |
|
|
2018
Q4 | $1.72M | Sell |
10,273
-122
| -1% | -$24.6K | 0.15% | 95 |
|
|
2018
Q3 | $2.34M | Sell |
10,395
-868
| -8% | -$202K | 0.19% | 79 |
|
|
2018
Q2 | $2.48M | Sell |
11,263
-1,660
| -13% | -$396K | 0.18% | 80 |
|
|
2018
Q1 | $3.25M | Sell |
12,923
-267
| -2% | -$69.5K | 0.22% | 64 |
|
|
2017
Q4 | $3.36M | Sell |
13,190
-649
| -5% | -$159K | 0.22% | 64 |
|
|
2017
Q3 | $3.28M | Sell |
13,839
-434
| -3% | -$97.9K | 0.22% | 60 |
|
|
2017
Q2 | $3.17M | Sell |
14,273
-1,145
| -7% | -$254K | 0.22% | 63 |
|
|
2017
Q1 | $3.54M | Buy |
15,418
+1,492
| +11% | +$360K | 0.24% | 57 |
|
|
2016
Q4 | $3.33M | Buy |
+13,926
| New | +$2.83M | 0.36% | 52 |
|
Other funds holding GS
SCI
RG
SMDAM
CAM
CAM
SFA
Cigna Investments's GS Position: Q2 2026 in Review
Cigna Investments reduced its Goldman Sachs (GS) stake by 2.5% in Q2 2026, selling an estimated $67.3K and leaving 2,738 shares worth $2.77M. The position accounts for 0.36% of the portfolio, ranked #45.
Cigna Investments first reported a position in GS in Q4 2016 and has held it in 39 quarters since. The position peaked at $4.03M in Q1 2021. 1,109 funds tracked by Wall St. Rank hold GS as of Q2 2026.
- Cigna Investments held 2,738 shares of Goldman Sachs worth $2.77M as of Q2 2026.
- Cigna Investments sold 69 Goldman Sachs shares in Q2 2026, an estimated $67.3K.
- Goldman Sachs made up 0.36% of Cigna Investments's portfolio in Q2 2026, its #45 holding.
- Cigna Investments first reported a position in Goldman Sachs in Q4 2016 and has held it in 39 quarters since.
- Cigna Investments's Goldman Sachs position peaked at $4.03M in Q1 2021.
- 1,109 funds tracked by Wall St. Rank held Goldman Sachs as of Q2 2026.
Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.